June 4, 2014:

FORGE Life Science LLC is awarded a second grant from the NIH National Institute for Allergy and Infectious Disease titled, “A Single Antiviral to Treat Multiple Opportunistic Infections” (1R43AI114079-01). Read more

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply